What question did this study set out to answer?

To evaluate nationwide population-based sarcoma incidence and analyze the distribution of histological subtypes in Germany.

February 12, 2018BMC Public HealthOpen Access

Strengthening health data on a rare and heterogeneous disease: sarcoma incidence and histological subtypes in Germany

View Full Paper

Ask AI

Bookmark

To evaluate nationwide population-based sarcoma incidence and analyze the distribution of histological subtypes in Germany.
Conducted a nationwide population-based epidemiological analysis using cancer registry data across Germany.
Calculated incidence rates across diverse sarcoma histological subtypes and compared them to European reference data from the RARECARE Project.
Identified German-wide population-based sarcoma incidence levels consistent with rates reported by the European RARECARE Project.
Established the first comprehensive nationwide epidemiological baseline for specific sarcoma histological subtypes.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Population-based study reveals national sarcoma incidence rates across histological subtypes in Germany, indicating alignment with European rare cancer surveillance benchmarks.

Cite This Study

Ressing et al. (2018) studied this question.

synapsesocial.com/papers/69d9a3555e5bcb4e3b837611 https://doi.org/10.1186/s12889-018-5131-4

View Full Paper

Ask AI

Bookmark

Implication

Population-based study reveals national sarcoma incidence rates across histological subtypes in Germany, indicating alignment with European rare cancer surveillance benchmarks.

Strengthening health data on a rare and heterogeneous disease: sarcoma incidence and histological subtypes in Germany

Key Points

Discussion

Implication

Cite This Study

Strengthening health data on a rare and heterogeneous disease: sarcoma incidence and histological subtypes in Germany

Key Points

Discussion

Implication

Cite This Study

Keep reading

Keep reading